ArticleFrontiers in neuroscience2026
Subtyping insomnia disorder with a population graph attention autoencoder: revealing two distinct biotypes.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insomnia disorder (ID) is neurobiologically heterogeneous and often eludes characterization by traditional group-level neuroimaging. Subtyping based on neuroimaging and clinical data offers a promising strategy for identifying biologically and clinically meaningful ID subgroups. To address this need, we developed a Gray Matter Population Graph Attention Autoencoder (GM-PGAAE) to subtype insomnia disorder in a cohort comprising 140 patients diagnosed with ID and 57 matched healthy controls. Each subject was represented as a node defined by atlas-based gray matter (GM) volumes. Population edges combined imaging-derived intersubject correlations with clinical similarity via a Hadamard product, generating an adjacency matrix that jointly encodes structural and phenotypic relationships. A Graph Attention Autoencoder learned low-dimensional embeddings that adaptively weighted informative intersubject connections, and clustering these embeddings identified distinct subtypes. Regional and network-level differences were further assessed using Voxel-Based Morphometry (VBM) and individualized differential structural covariance networks (IDSCNs). Through this framework, two ID subtypes were identified. Compared with Subtype 2, Subtype 1 showed higher symptom severity and greater GM reductions-particularly in the cerebellar vermis, thalamus, middle occipital cortex, fusiform gyrus, and paracentral lobule-alongside negative associations between GM volume and clinical scores. IDSCNs further revealed reduced thalamocortical and subcortical Z-scores in Subtype 1, indicating subtype-specific network alterations. Overall, GM-PGAAE integrates structural MRI and clinical measures to derive individualized embeddings and delineate biologically distinct ID subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.